Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
48.31
+1.28 (2.72%)
Nov 22, 2024, 4:00 PM EST - Market closed
Vera Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -134.38 | -95.99 | -89.06 | -32.61 | -53.41 | -11.85 |
| Depreciation & Amortization | -4.05 | -4.09 | -0.85 | 0.18 | 0.25 | 0.51 |
| Other Amortization | - | - | - | - | 0.02 | - |
| Loss (Gain) From Sale of Assets | - | - | - | -2.69 | - | 0.09 |
| Asset Writedown & Restructuring Costs | - | - | - | -1 | 3.61 | 0.18 |
| Loss (Gain) From Sale of Investments | 0.05 | 0.05 | 0.81 | 0.89 | - | - |
| Stock-Based Compensation | 17.81 | 11.49 | 8.89 | 3.01 | 0.33 | 0.26 |
| Other Operating Activities | -1.33 | 2.22 | 5.86 | 5 | 14.27 | - |
| Change in Accounts Payable | -7.7 | -0.87 | 10.61 | 0.48 | 0.57 | -0.29 |
| Change in Other Net Operating Assets | 8.96 | -5 | -3.86 | 3.04 | -0.44 | 0.81 |
| Operating Cash Flow | -120.64 | -92.18 | -67.6 | -23.71 | -34.81 | -10.29 |
| Capital Expenditures | -0.39 | -0.06 | -0.06 | - | -0.1 | -0.13 |
| Sale of Property, Plant & Equipment | - | - | - | 0.8 | 0.06 | - |
| Sale (Purchase) of Intangibles | - | - | - | -5 | - | - |
| Investment in Securities | -184.7 | -39.37 | -70.49 | - | - | - |
| Investing Cash Flow | -185.09 | -39.43 | -70.55 | -4.2 | -0.04 | -0.13 |
| Short-Term Debt Issued | - | - | - | - | 5.6 | - |
| Long-Term Debt Issued | - | 24.74 | 19.82 | 4.92 | - | - |
| Total Debt Issued | 24.74 | 24.74 | 19.82 | 4.92 | 5.6 | - |
| Long-Term Debt Repaid | - | - | - | - | -0.13 | -0.19 |
| Net Debt Issued (Repaid) | 24.74 | 24.74 | 19.82 | 4.92 | 5.47 | -0.19 |
| Issuance of Common Stock | 298.69 | 116.06 | 88.21 | 51.73 | 0.23 | 0.05 |
| Other Financing Activities | -17.87 | -7.26 | -6.1 | -2.77 | -0.41 | - |
| Financing Cash Flow | 305.55 | 133.54 | 101.93 | 53.88 | 85.29 | -0.14 |
| Net Cash Flow | -0.19 | 1.93 | -36.22 | 25.97 | 50.44 | -10.55 |
| Free Cash Flow | -121.03 | -92.24 | -67.66 | -23.71 | -34.91 | -10.41 |
| Free Cash Flow Per Share | -2.36 | -2.16 | -2.55 | -1.76 | -109.10 | -35.26 |
| Cash Interest Paid | 5.84 | 3.35 | 0.9 | 0.02 | 0.03 | 0.05 |
| Levered Free Cash Flow | -78.35 | -62.13 | -42.37 | -20.38 | -29.09 | - |
| Unlevered Free Cash Flow | -74.09 | -59.76 | -41.75 | -20.37 | -29.01 | - |
| Change in Net Working Capital | -3.35 | 3.35 | -7.08 | -2.94 | -1.28 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.